期刊文献+

卡托普利防治老年冠脉造影或介入治疗造影剂肾病55例临床观察 被引量:4

Clinical Observation on Captopril in the Prevention and Treatment of Radiographic Contrast Nephropathy After Coronary Angiography or Interventional Therapy in Elderly Patients
下载PDF
导出
摘要 目的探讨卡托普利防治老年冠状动脉粥样硬化性心脏病(简称冠心病)患者冠状动脉造影或介入治疗术后造影剂肾病的临床效果及作用机制。方法选择医院2016年1月至2017年1月接受冠状动脉造影或介入治疗的老年冠心病患者110例,随机分为对照组和治疗组,各55例。对照组患者于使用造影剂前24 h至术后48 h服用安慰剂淀粉片,而治疗组患者则同期口服卡托普利片。结果造影后,两组患者的血清肌酐(SCr)水平明显上升,肌酐清除率(CCr)及肾小球滤过率(GFR)均明显下降(P<0.05);治疗组患者的肾小球功能损伤程度比对照组更低;造影后72 h,两组患者的上述指标均优于造影后48 h;对照组患者血清GFR,SCr,CCr水平与造影前比较,差异有统计学意义(P<0.05);治疗组造影剂肾病发生率为3.64%,明显低于对照组的7.27%(P<0.05)。结论老年冠心病患者冠状动脉造影或介入治疗术中所用造影剂会影响肾小球功能,继而导致肾小球肾病,而卡托普利可有效防治和减轻造影剂肾病。 Objective To investigate the clinical effect of captopril in the prevention and treatment of coronary angiography or radiographic contrast nephropathy after interventional therapy in elderly patients with coronary heart disease and its mechanism of action.Methods Totally 110 elderly patients with coronary heart disease undergoing coronary angiography or interventional therapy in our hospital from January 2016 to January 2017 were selected and randomly divided into the control group and the treatment group,55 cases in each group.The control group was given Placebo Starch Tablets from 24h before the contrast agent to 48h after the operation,while the treatment group was given Captopril Tablets in the same period.Results After angiography,the serum serum creatinine(SCr)levels of the two groups were significantly increased,the creatinine clearance rate(CCr)and glomerular filtration rate(CFR)were significantly decreased(P<0.05),The damage degree of glomerular function in the treatment group was lower than that in the control group(P<0.05).Compared with 48h after angiography,the above indexes in the two groups were better at 72 h after angiography(P<0.05).The serum GFR,SCr and CCr levels in the control group were significantly different from those before angiography(P<0.05).The incidence rate of radiographic contrast nephropathy in the treatment group was 3.63%,which was significantly lower than 7.27%in the control group(P<0.05).Conclusion Contrast agents used in coronary angiography or interventional therapy in elderly patients with coronary heart disease may affect the glomeruli function and lead to glomerular nephropathy,but captopril can effectively prevent and reduce radiographic contrast nephropathy.
作者 杜艳彬 袁祖军 白亚君 Du Yanbin;Yuan Zujun;Bai Yajun(Department of Nephrology,Nanchong Central Hospital,Nanchong,Sichuan,China 637000)
出处 《中国药业》 CAS 2018年第6期57-59,共3页 China Pharmaceuticals
关键词 冠状动脉粥样硬化性心脏病 老年 造影剂肾病 肾损害 卡托普利 作用机制 coronary heart disease elderly contrast nephropathy kidney damage captopril mechanism of actio
  • 相关文献

参考文献10

二级参考文献115

  • 1潘永东,杨树森.造影剂对冠脉介入诊疗患者肾功能的影响[J].齐齐哈尔医学院学报,2009,30(4):392-394. 被引量:5
  • 2蒙兰芬,龚智峰.造影剂肾病的研究进展[J].中国医学文摘(老年医学),2005,14(1):61-66. 被引量:9
  • 3张庆娟(综述),刘殿阁(审校).造影剂肾病的防治进展[J].国际泌尿系统杂志,2007,27(1):117-120. 被引量:15
  • 4Briguori C, Airoldi F, Morici N, et al. New pharmacological protocols to prevent or reduce contrast media nephropathy[J]. Minerva Cardioangiol, 2005, 53 ( 1 ) : 49 - 58.
  • 5Cavusoglu E, Chhabra S, Marmur JD, et al. The prevention of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention [J]. Minerva Cardioangiol, 2004, 52 (5) : 419 - 432.
  • 6Thomsen HS. Guidelines for contrast media from the European Society of Urogenital Radiology[J]. Am J Roentgenol, 2003, 181 (6): 1 463 - 1 471.
  • 7Heyman SN, Goldfarb M, Shira A, et al. Nacetylcysteine a meliorates renal microcirculation: studies in rats [J] .Kidney Int, 2003, 63(2): 634 - 641.
  • 8Zager RA, Johnson AC, Hanson SY. Radiographic contrast media-induced tubular injury: evaluation of oxidant stress and plasma membrane integrity [J]. Kidney Int, 2003, 64(1 ): 128 - 139.
  • 9Alonso A, Lau J, Jaber BL, et al. Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta -analysis of randomized, controlled trials [J].Am J Kidnet Dis, 2004,43(1): 19.
  • 10Isenbarger DW, Kent SM, O' Malley PG. Meta-analysis of randomized clinical trials on the usefulness of acetyleysteine for prevention of contrast nephropathy[J]. Am J Cardiol, 2003, 92(12): 1454 - 1 458.

共引文献62

同被引文献38

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部